Literature DB >> 25385800

Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.

Christian Pustelny1, Uliana Komor2, Vinay Pawar2, Anne Lorenz1, Agata Bielecka1, Annette Moter3, Benjamin Gocht3, Denitsa Eckweiler1, Mathias Müsken1, Claudia Grothe4, Heinrich Lünsdorf5, Siegfried Weiss2, Susanne Häussler6.   

Abstract

The recent finding that high numbers of strict anaerobes are present in the respiratory tract of cystic fibrosis (CF) patients has drawn attention to the pathogenic contribution of the CF microbiome to airway disease. In this study, we investigated the specific interactions of the most dominant bacterial CF pathogen, Pseudomonas aeruginosa, with the anaerobic bacterium Veillonella parvula, which has been recovered at comparable cell numbers from the respiratory tract of CF patients. In addition to growth competition experiments, transcriptional profiling, and analyses of biofilm formation by in vitro studies, we used our recently established in vivo murine tumor model to investigate mutual influences of the two pathogens during a biofilm-associated infection process. We found that P. aeruginosa and V. parvula colonized distinct niches within the tumor. Interestingly, significantly higher cell numbers of P. aeruginosa could be recovered from the tumor tissue when mice were coinfected with both bacterial species than when mice were monoinfected with P. aeruginosa. Concordantly, the results of in vivo transcriptional profiling implied that the presence of V. parvula supports P. aeruginosa growth at the site of infection in the host, and the higher P. aeruginosa load correlated with clinical deterioration of the host. Although many challenges must be overcome to dissect the specific interactions of coinfecting bacteria during an infection process, our findings exemplarily demonstrate that the complex interrelations between coinfecting microorganisms and the immune responses determine clinical outcome to a much greater extent than previously anticipated.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25385800      PMCID: PMC4288896          DOI: 10.1128/IAI.02234-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease).

Authors:  Magdalena Strach; Maciej Siedlar; Danuta Kowalczyk; Marek Zembala; Tomasz Grodzicki
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Microstructural differences between single-species and dual-species biofilms of Streptococcus mutans and Veillonella parvula, before and after exposure to chlorhexidine.

Authors:  Duygu Kara; Suzanne B I Luppens; Jan van Marle; Rifat Ozok; Jacob M ten Cate
Journal:  FEMS Microbiol Lett       Date:  2007-04-02       Impact factor: 2.742

Review 3.  Prosthetic valve endocarditis caused by Veillonella parvula.

Authors:  T W Boo; B Cryan; A O'Donnell; G Fahy
Journal:  J Infect       Date:  2005-01       Impact factor: 6.072

Review 4.  Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy?

Authors:  D Marriott; D Stark; J Harkness
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

5.  Diversity of Veillonella spp. from sound and carious sites in children.

Authors:  N Arif; E C Sheehy; T Do; D Beighton
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

6.  Effect of Veillonella parvula on the antimicrobial resistance and gene expression of Streptococcus mutans grown in a dual-species biofilm.

Authors:  S B I Luppens; D Kara; L Bandounas; M J Jonker; F R A Wittink; O Bruning; T M Breit; J M Ten Cate; W Crielaard
Journal:  Oral Microbiol Immunol       Date:  2008-06

7.  Containment of tumor-colonizing bacteria by host neutrophils.

Authors:  Kathrin Westphal; Sara Leschner; Jadwiga Jablonska; Holger Loessner; Siegfried Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Veillonella as a cause of chronic anaerobic pneumonitis.

Authors:  Ashok Shah; Chandramani Panjabi; Vidya Nair; Rama Chaudhry; S S Thukral
Journal:  Int J Infect Dis       Date:  2008-06-10       Impact factor: 3.623

9.  An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants.

Authors:  Nicole T Liberati; Jonathan M Urbach; Sachiko Miyata; Daniel G Lee; Eliana Drenkard; Gang Wu; Jacinto Villanueva; Tao Wei; Frederick M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

View more
  16 in total

Review 1.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

2.  Antibiotic treatment and stewardship in the era of microbiota-oriented diagnostics.

Authors:  Debby Bogaert; Alex van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-06       Impact factor: 3.267

3.  Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.

Authors:  Jasmohan S Bajaj; Nita H Salzman; Chathur Acharya; Richard K Sterling; Melanie B White; Edith A Gavis; Andrew Fagan; Michael Hayward; Mary L Holtz; Scott Matherly; Hannah Lee; Majdi Osman; Mohammad S Siddiqui; Michael Fuchs; Puneet Puri; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2019-06-18       Impact factor: 17.425

4.  In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.

Authors:  Vinay Pawar; Uliana Komor; Nadine Kasnitz; Piotr Bielecki; Marina C Pils; Benjamin Gocht; Annette Moter; Manfred Rohde; Siegfried Weiss; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

5.  Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome.

Authors:  Priti Devi; Ranjeet Maurya; Priyanka Mehta; Uzma Shamim; Aanchal Yadav; Partha Chattopadhyay; Akshay Kanakan; Kriti Khare; Janani Srinivasa Vasudevan; Shweta Sahni; Pallavi Mishra; Akansha Tyagi; Sujeet Jha; Sandeep Budhiraja; Bansidhar Tarai; Rajesh Pandey
Journal:  Microbiol Spectr       Date:  2022-05-17

6.  The Salivary Microbiome and Oral Cancer Risk: a Pilot Study in Fanconi Anemia.

Authors:  C P Furquim; G M S Soares; L L Ribeiro; M A Azcarate-Peril; N Butz; J Roach; K Moss; C Bonfim; C C Torres-Pereira; F R F Teles
Journal:  J Dent Res       Date:  2016-11-13       Impact factor: 6.116

7.  The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway.

Authors:  Bojana Mirković; Michelle A Murray; Gillian M Lavelle; Kevin Molloy; Ahmed Abdul Azim; Cedric Gunaratnam; Fiona Healy; Dubhfeasa Slattery; Paul McNally; Joe Hatch; Matthew Wolfgang; Michael M Tunney; Marianne S Muhlebach; Rosaleen Devery; Catherine M Greene; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

Review 8.  Potential Contributions of Anaerobes in Cystic Fibrosis Airways.

Authors:  Christina S Thornton; Michael G Surette
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

9.  Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.

Authors:  Jun-Chieh J Tsay; Benjamin G Wu; Michelle H Badri; Jose C Clemente; Nan Shen; Peter Meyn; Yonghua Li; Ting-An Yie; Tenzin Lhakhang; Evan Olsen; Vivek Murthy; Gaetane Michaud; Imran Sulaiman; Aristotelis Tsirigos; Adriana Heguy; Harvey Pass; Michael D Weiden; William N Rom; Daniel H Sterman; Richard Bonneau; Martin J Blaser; Leopoldo N Segal
Journal:  Am J Respir Crit Care Med       Date:  2018-11-01       Impact factor: 21.405

Review 10.  From Input to Output: The Lap/c-di-GMP Biofilm Regulatory Circuit.

Authors:  Alan J Collins; T Jarrod Smith; Holger Sondermann; George A O'Toole
Journal:  Annu Rev Microbiol       Date:  2020-07-20       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.